Search Results
You are looking at 1 - 5 of 5 items for
- Author: M O'Hare x
- Refine by access: All content x
Search for other papers by M. J. O'HARE in
Google Scholar
PubMed
SUMMARY
The metabolism of [3H]corticosterone by freshly disaggregated suspensions and deliberately damaged monolayer cultures of rat adrenocortical cells has been examined. In both cases, increased yields of 11-dehydrocorticosterone were obtained compared with intact, undamaged monolayer cultures, in which effective 11-dehydrogenase activity was extremely low. It was concluded that the greater part of the effective 11-dehydrogenase activity of the freshly prepared adrenal cell suspension was due to cells damaged by the disaggregation procedure. The maximum rate at which corticosterone was converted to 11-dehydrocorticosterone by the suspensions was equivalent to at least 50 ng/million cells/h. Undamaged monolayer cultures did not metabolize more than 0·2 ng of corticosterone/million cells/h to 11-dehydrocorticosterone.
Search for other papers by M. J. O'HARE in
Google Scholar
PubMed
Search for other papers by A. MUNRO NEVILLE in
Google Scholar
PubMed
SUMMARY
The patterns of exogenous steroid metabolism by rat adrenocortical zona fasciculata and zona reticularis cells cultured together as a monolayer have been examined. In the continued presence of corticotrophin (ACTH), the cultured cells synthesized corticosterone, 18-hydroxydeoxycorticosterone and deoxycorticosterone from [3H]pregnenolone. In the prolonged absence of ACTH, however, [3H]pregnenolone was metabolized mainly to progesterone, 20α-dihydroprogesterone, 20α-hydroxy-5α-pregnan-3-one and 5α-pregnane-3β,20α-diol with small amounts of 5α-pregnane-3,20-dione, 11β-hydroxyprogesterone and 11β-hydroxy-20α-dihydroprogesterone, while virtually no corticosterone, 18-hydroxydeoxycorticosterone or deoxycorticosterone were produced. While 5-ene-3β-hydroxysteroid dehydrogenase-isomerase activity persisted at a substantial level in unstimulated cells and the 11β- and 18-hydroxylases were reduced but still present, 21-hydroxylase activity was almost completely lost when ACTH was omitted from the culture medium. These changes in enzyme activities were completely reversed by the addition of ACTH, cyclic AMP or dibutyryl cyclic AMP to unstimulated cultures for 4–5 days, during which time no proliferation of adrenal cells was observed.
Search for other papers by M. J. O'HARE in
Google Scholar
PubMed
Search for other papers by A. MUNRO NEVILLE in
Google Scholar
PubMed
SUMMARY
Confluent monolayer cultures of cells from the zona fasciculata and zona reticularis of the normal adult rat adrenal cortex were maintained with or without corticotrophin (ACTH) for up to 4 months, without proliferation of adrenal cells. Proliferating fibroblast-like cells, however, eventually overgrew the adrenal monolayer in cultures both with and without ACTH. Adrenocortical cells in culture, maintained without ACTH, spread rapidly to form a confluent monolayer, whereas cell spreading was markedly inhibited in the presence of ACTH. Exposure of previously unstimulated cells to ACTH or cyclic AMP caused the adrenal cells to retract with loss of confluence, the process being reversed when ACTH or cyclic AMP was withdrawn. Ultrastructural features of cells cultured with ACTH were typical of normal adrenocortical cells; in cultures without ACTH they were similar to those of adrenocortical cells found in the hypophysectomized rat.
Search for other papers by M. J. O'HARE in
Google Scholar
PubMed
Search for other papers by A. MUNRO NEVILLE in
Google Scholar
PubMed
SUMMARY
Quantitative aspects of corticosteroidogenesis were examined in monolayer cultures of cells from the zona fasciculata and zona reticularis of the adult rat adrenal cortex, maintained for up to 4 months. Corticosterone secretion continued at a steady rate in cultures maintained with corticotrophin (ACTH), the output of maximally stimulated cultures being approximately 12 μg/106 adrenocortical cells/day. In the absence of ACTH, a small amount of 20α-hydroxypregn-4-en-3-one, but no detectable corticosterone, was secreted, resulting in a fluorogenic steroid output 1/125 th of that of maximally stimulated cultures. Restimulation with ACTH of cultures maintained for up to 2 months in its absence resulted in maximum levels of corticosterone secretion after 4–5 days of continuous ACTH treatment. The levels of corticosterone secretion attained on restimulation were similar to those observed in cultures maintained with ACTH from the out set. Withdrawal of ACTH resulted in a fall in steroid output which took 10 days to reach final unstimulated levels. Trophic stimulation of corticosteroidogenesis with a similar time-course was obtained with both cyclic AMP and dibutyryl cyclic AMP, the latter being the more effective.
Search for other papers by C Palmieri in
Google Scholar
PubMed
Search for other papers by D Roberts-Clark in
Google Scholar
PubMed
Search for other papers by A Assadi-Sabet in
Google Scholar
PubMed
Search for other papers by RC Coope in
Google Scholar
PubMed
Search for other papers by M O'Hare in
Google Scholar
PubMed
Search for other papers by A Sunters in
Google Scholar
PubMed
Search for other papers by A Hanby in
Google Scholar
PubMed
Search for other papers by MJ Slade in
Google Scholar
PubMed
Search for other papers by JJ Gomm in
Google Scholar
PubMed
Search for other papers by EW Lam in
Google Scholar
PubMed
Search for other papers by RC Coombes in
Google Scholar
PubMed
Keratinocyte growth factor/fibroblast growth factor 7 (KGF/FGF7) is known to be a potent growth factor for mammary cells but its origin, cellular targets and mode of action in the breast are unclear. In this study, we carried out studies to determine the localisation of FGF7 and its receptor, and the related growth factor FGF10. We also determined the factors that regulate FGF7 release from stromal cells and the effects of FGF7 on normal and neoplastic breast cells. Using an FGF7-specific antibody which does not react with the FGF7 heparan sulphate proteoglycan (HSPG)-binding site, we showed epithelial and myoepithelial immunohistochemical staining in normal breast sections, and epithelial staining in breast carcinomas. Stromal staining was also detected in some lobular carcinomas as well as a subset of invasive ductal carcinomas. FGF10 and FGF receptor (FGFR)2 immunostaining showed a similar epithelial expression pattern, whereas no stromal staining was observed. We purified normal breast stromal, epithelial and myoepithelial cells and showed that FGF7 stimulated proliferation of both epithelial cell types, but not stromal fibroblasts. We also examined the effects of FGF7 on Matrigel-embedded organoids, containing both epithelial and myoepithelial cells, and showed FGF7 induced an increase in cellular proliferation. Furthermore, conditioned medium derived from stromal cells was shown to increase the proliferation of normal and neoplastic breast epithelial cells, which could be abolished by a neutralising antibody to FGF7. Finally, we showed that interleukin-1beta, but not oestradiol or other oestrogen receptor ligands, caused a dose-related FGF7 release. Further results also indicate that the epithelial localisation of FGF7 and FGF10 in breast tissue sections is likely to be due to their binding to their cognate receptor. In summary, our findings suggest that FGF7 is a paracrine growth factor in the breast. FGF7 is produced by the breast stromal fibroblasts and has profound proliferative and morphogenic roles on both epithelial and myoepithelial cells.
